Skip to main content
View:
Download DOC
Download PDF
Download XLS
Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 27, 2024
Accession Number:
0001213900-24-111996
Submission Type:
POS AM
CIK:
0001191070
Company Name:
Neuphoria Therapeutics Inc.
File Number:
333-280288